You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

solid tumors

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Secondary Malignant Tumor of Liver Trial in Guangzhou (Cryosurgery, NK Immunotherapy)

Completed
  • Secondary Malignant Neoplasm of Liver
  • Cryosurgery
  • NK Immunotherapy
  • Guangzhou, Guangdong, China
    Cancer Institute in Fuda cancer hospital
Sep 10, 2019

Correlation of Microbiome and Metabonomics With IgA Nephropathy

Recruiting
  • IgA Nephropathy
    • Guangzhou, Guangdong, China
    • +4 more
    Jan 12, 2022

    Metastatic Malignant Tumor, Solid Tumor, Unresectable Malignant Tumor Trial in Chicago (Ilorasertib, Laboratory Biomarker

    Completed
    • Metastatic Malignant Neoplasm
    • +2 more
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    Apr 18, 2019

    Advanced Melanoma, Melanoma of Unknown Primary, Mucosal Melanoma Trial in United States (Ipilimumab, Nivolumab)

    Active, not recruiting
    • Advanced Melanoma
    • +10 more
    • Ipilimumab
    • Nivolumab
    • Anchorage, Alaska
    • +638 more
    Aug 30, 2022

    Type 2 Diabetes, Obesity Trial in Toronto (Dietary intervention)

    Completed
    • Type 2 Diabetes Mellitus
    • Obesity
    • Dietary intervention
    • Toronto, Ontario, Canada
      Department of Nutritional Sciences, FitzGerald Building
    Nov 2, 2020

    Bladder Cancer, Gastric Cancer Trial in Philadelphia (OTL38, ICG)

    Completed
    • Bladder Cancer
    • Gastric Cancer
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Jun 11, 2021

    Castration-resistant Prostate Cancer, Metastasis Trial in France (Carboplatin)

    Terminated
    • Castration-resistant Prostate Cancer
    • Metastasis
    • Caen, France
    • +3 more
    Apr 28, 2021

    Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

    Recruiting
    • Urinary Bladder Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Brain Tumor, Cancer Trial run by the National Cancer Institute (NCI) (Zotiraciclib)

    Not yet recruiting
    • Brain Tumor
    • Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Blood Vessel Perforation Trial in Guangzhou (perforator locator)

    Recruiting
    • Blood Vessel Perforation
    • perforator locator
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Jun 21, 2023

    Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

    Recruiting
    • Astrocytoma, Grades II, III and IV
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

    Recruiting
    • Glioblastoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Neurofibromatosis 1 (NF1), Plexiform Neurofibromas (PN) Trial run by the NCI (Selumetinib)

    Active, not recruiting
    • Neurofibromatosis 1 (NF1)
    • Plexiform Neurofibromas (PN)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Voiding Disorders in Children After Sacrococcygeal Teratoma

    Completed
    • Sacrococcygeal Teratoma
    • +2 more
      • Montpellier, France
        University hospital of Montpellier
      Jan 10, 2022

      Colorectal Cancer Trial in Nagoya, Sunto-gun, Tokyo (OCV-103 and OCV-104)

      Completed
      Has Results
      • Colorectal Cancer
      • OCV-103 and OCV-104
      • Nagoya, Japan
      • +2 more
      Feb 9, 2021

      Anxiety Trial run by the National Cancer Institute (NCI) (Pico G2 4K Headset with Applied VR software)

      Recruiting
      • Anxiety
      • Pico G2 4K Headset with Applied VR software
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 30, 2023

      Triple Negative Breast Tumors Trial (Pembrolizumab, Nab-paclitaxel, Anthracycline (doxorubicin))

      Completed
      Has Results
      • Triple Negative Breast Neoplasms
      • Pembrolizumab
      • +5 more
      • (no location specified)
      Aug 21, 2020

      Adrenal Incidentaloma, Adrenocortical Carcinoma Trial in Groningen

      Recruiting
      • Adrenal Incidentaloma
      • Adrenocortical Carcinoma
        • Groningen, Netherlands
          University Medical Center Groningen
        Sep 29, 2021

        Tumors Trial in Minneapolis (852A)

        Completed
        • Neoplasms
        • Minneapolis, Minnesota
          University of Minnesota
        Nov 27, 2017

        Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

        Completed
        Has Results
        • Distal Urethral Cancer
        • +10 more
        • Gemcitabine hydrochloride
        • +3 more
        • Springfield, Missouri
        • +1 more
        Sep 17, 2020

        Pancreatic Ductal Adenocarcinoma Trial in Durham (HA Chemotherapy)

        Not yet recruiting
        • Pancreatic Ductal Adenocarcinoma
        • HA Chemotherapy
        • Durham, North Carolina
          Duke University Health System
        Nov 22, 2022

        Advanced or Metastatic Solid Tumors, Advanced or Metastatic Breast Cancer Trial in Salt Lake City (Azacitidine (Vidaza),

        Completed
        Has Results
        • Advanced or Metastatic Solid Tumors
        • Advanced or Metastatic Breast Cancer
        • Azacitidine (Vidaza)
        • Nab-paclitaxel (Abraxane)
        • Salt Lake City, Utah
          University of Utah Huntsman Cancer Institute
        Jun 27, 2017

        Gynecologic Surgical Procedures Trial in Bron (Cellvizio®)

        Recruiting
        • Gynecologic Surgical Procedures
        • Cellvizio®
        • Bron, France
        • +1 more
        Mar 22, 2022

        Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Atlanta (Nivolumab)

        Withdrawn
        • Recurrent Non-Small Cell Lung Carcinoma
        • Stage IV Non-Small Cell Lung Cancer
        • Nivolumab
        • Atlanta, Georgia
        • +1 more
        May 17, 2019

        Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7 Trial in United States (Endoxifen

        Active, not recruiting
        Has Results
        • Recurrent Breast Carcinoma
        • +5 more
        • Endoxifen Hydrochloride
        • +3 more
        • Mobile, Alabama
        • +566 more
        Sep 1, 2021